Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard Lerer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Npj Aging|April 3, 2026
Psilocybin and human longevityLeonard Lerer
Nature Biotechnology|March 5, 2002
Real options for biotechnology valuationMichael Harrison, Leonard Lerer
Psychedelic Medicine (New Rochelle, N.Y.)|March 6, 2025
<i>Incilius alvarius</i> Cell-Based Synthesis of 5-Methoxy-N,N-DimethyltryptamineLeonard Lerer, Eric Reynolds, Jeet Varia, et al.
Frontiers in Psychiatry|April 11, 2022
Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health OutcomesRichard Matzopoulos, Robert Morlock, Amy Morlock, et al.
Frontiers in Psychiatry|January 20, 2022
Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health OutcomesRichard Matzopoulos, Robert Morlock, Amy Morlock, et al.
Frontiers in Psychiatry|March 20, 2025
Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021Sofia Abramsky-Sze, Elliot Marseille, Richard Matzopoulos, et al.
Frontiers in Psychiatry|May 6, 2026
Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021Sofia Abramsky-Sze, Elliot Marseille, Richard Matzopoulos, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-GroomingMichal Brownstien, Michal Lazar, Alexander Botvinnik, et al.
Molecular Psychiatry|October 11, 2024
Striking long-term beneficial effects of single dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-groomingMichal Brownstien, Michal Lazar, Alexander Botvinnik, et al.
Molecular Psychiatry|October 25, 2022
Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementationGilly Wolf, Sandeep Singh, Karin Blakolmer, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Npj Aging|April 3, 2026
Psilocybin and human longevityLeonard Lerer
Nature Biotechnology|March 5, 2002
Real options for biotechnology valuationMichael Harrison, Leonard Lerer
Psychedelic Medicine (New Rochelle, N.Y.)|March 6, 2025
<i>Incilius alvarius</i> Cell-Based Synthesis of 5-Methoxy-N,N-DimethyltryptamineLeonard Lerer, Eric Reynolds, Jeet Varia, et al.
Frontiers in Psychiatry|April 11, 2022
Corrigendum: Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health OutcomesRichard Matzopoulos, Robert Morlock, Amy Morlock, et al.
Frontiers in Psychiatry|January 20, 2022
Psychedelic Mushrooms in the USA: Knowledge, Patterns of Use, and Association With Health OutcomesRichard Matzopoulos, Robert Morlock, Amy Morlock, et al.
Frontiers in Psychiatry|March 20, 2025
Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021Sofia Abramsky-Sze, Elliot Marseille, Richard Matzopoulos, et al.
Frontiers in Psychiatry|May 6, 2026
Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021Sofia Abramsky-Sze, Elliot Marseille, Richard Matzopoulos, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-GroomingMichal Brownstien, Michal Lazar, Alexander Botvinnik, et al.
Molecular Psychiatry|October 11, 2024
Striking long-term beneficial effects of single dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-groomingMichal Brownstien, Michal Lazar, Alexander Botvinnik, et al.
Molecular Psychiatry|October 25, 2022
Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementationGilly Wolf, Sandeep Singh, Karin Blakolmer, et al.
Pageof 2